{"schema_version":"secwatch.filing_event.v1","accession":"0001193805-25-000730","form_type":"8-K","ticker":"IMUX","cik":"0001280776","company_name":"IMMUNIC, INC.","filed_at":"2025-05-28T23:59:59+00:00","discovered_at":"2026-05-14T18:02:47.826923+00:00","generated_at":"2026-05-20T07:36:25.302283+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"medium","headline":"Immunic announces public offering of warrants and posts extended phase 2 CALLIPER data","bullets":["Commenced underwritten public offering of pre-funded warrants and Series A (expire Dec 31, 2025) and Series B (5-year) warrants.","Leerink Partners sole bookrunner; proceeds to fund clinical trials and general corporate purposes.","Posted updated corporate presentation with extended data from phase 2 CALLIPER trial of vidofludimus calcium in progressive MS.","Offering is subject to market conditions; no assurance of completion or final terms."],"urls":{"canonical":"https://secwatch.observer/filing/0001193805-25-000730","json":"https://secwatch.observer/filing/0001193805-25-000730.json","markdown":"https://secwatch.observer/filing/0001193805-25-000730.md","text":"https://secwatch.observer/filing/0001193805-25-000730.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1280776/000119380525000730/0001193805-25-000730-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1280776/000119380525000730/e664552_8k-immuniclaunch.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-20T07:36:25.302283+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}